SFM
VBIV

Signet Financial Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Signet Financial Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-500
Closed -$8K – 259
2019
Q3 		$8K Buy
+500
New +$10.5K ﹤0.01% 239

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Signet Financial Management's VBIV Position: Q4 2019 in Review

Signet Financial Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2019, closing a stake of 500 shares — an estimated $8K sold.

Signet Financial Management first reported a position in VBIV in Q3 2019 and held it in 1 quarter. The position peaked at $8K in Q3 2019. 75 funds tracked by Wall St. Rank hold VBIV as of Q4 2019.

  • Signet Financial Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2019 after selling out during the quarter.
  • Signet Financial Management sold 500 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2019, an estimated $8K.
  • Signet Financial Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2019 and held it in 1 quarter.
  • Signet Financial Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $8K in Q3 2019.
  • 75 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2019.

Based on Signet Financial Management's 13F filing for Q4 2019, filed 23 Jan 2020.